Loading...

PR Information Data

A new turning point in cancer treatment, the 8th IVRA 2025, will be held in Seoul.
25-05-26 17:08 38회 0건

A new turning point in cancer treatment, the 8th IVRA 2025, will be held in Seoul.

On June 22, at Seoul St. Mary's Hospital, the latest clinical research results and the recent knowledge on cancer treatment will be exchanged.

본문이미지 확대보기

Health News An international conference that will be a new turning point in cancer treatment, sharing the latest clinical data in the field of cancer treatment and exploring the direction of future medical technology, will be held in Seoul.

 

The Organizing Committee of the International Virus Research Alliance (IVRA) announced that the 8th IVRA 2025 International Medical Conference will be held at the Maria Hall of the Catholic University of Korea Seoul St. Mary's Hospital's Seongui Hall on June 22 from 9:00 AM to 5:00 PM.

 

This academic conference is sponsored by AdipoLABs Inc. and will be attended by medical experts and cancer patients from Korea and abroad, as well as medical scholars from over 20 countries around the world, who will share the latest clinical research results and cutting-edge treatment knowledge in cancer treatment.

In addition, the event is adding its academic credibility through support from major institutions such as Seoul St. Mary's Hospital of Catholic University of Korea, Korean Society for Thermal Medicine, Wonju Severance Christian Hospital, Korean Society of Emergency Physicians, and Korean Society of Balance Medicine.

 

In particular, the main speakers will include Professor Kim Eui-shin (MD Anderson Lifetime Professor, USA), a world-renowned authority on cancer treatment, Professors Jang Hong-seok, Kang Young-nam, and Choi Gyu-hye (Department of Radiation Oncology, Seoul St. Mary's Hospital), Professor Hyun Myung (Ilsan Cha Hospital), Director Lee Chan-yong (Seoul Oncare), Director Shin Hyeong-jin (EM365 Clinic), Director Yang Jae-ho (Jongno Chihu Oriental Hospital), Director Ryu Jeong-man (Cheongju Nabysol Oriental Hospital), and Director Kim Jeong-hoon (Daegu Happy H Hospital).

 

In addition, overseas speakers, including Dr. Nagraj G. Huilgol (India), Dr. Kenny Yong Yean Sirn (Malaysia), Dr. Brendan Chia Seng Hup (Singapore), and Dr. Taufiq Bin Jemain (Australia), will participate and share the recent cancer treatment cases from each country.

 

 Furthermore, Dr. Jang Sang-geun (former president of Konkuk University Hospital), Dr. Kim Seung-jo (President of SKJ Sangkyungwon in Yeoju, Gyeonggi Province), Professor Lee Kang-hyun (former president of Wonju Severance Hospital), and President Kim Gyeong-jin (Korean Society of Balance Medicine) will serve as moderators and lead the seminar.

 

This academic conference is expected to be a meaningful opportunity to share the upgraded clinical data in the field of cancer treatment and discuss the direction of future medical technology based on the founding spirit of IVRA, which seeks to liberate humanity from disease and suffering.

 

The 8th conference, which is being held amid the attention of the international medical community, is expected to be a paramount milestone that continues the international authority and reputation of the 7th event held in Indonesia last year.

 

IVRA emphasized that “this conference will be a place to explore the advancement of cancer treatment technology and the direction of medical cooperation while providing practical discussions for a secured future for humanity,” and that “it is an important academic event that realizes the founding principle of IVRA, which is to liberate humanity from disease and suffering.”

 

On the other hand, AdipoLABs’ CEO Han Sung-ho said, “Since its establishment with the noble mission of ‘liberating humanity from disease and suffering,’ IVRA has presented various therapeutic possibilities for virus research and cancer treatment.” He continued, “The 8th IVRA Academic Seminar will go beyond mere academic achievements and become a practical hope that will save and restore the lives of individual patients through the clinical achievements and treatment experiences that we will disseminate.”

 

Meanwhile, applications for participation in this international conference and detailed inquiries can be made through the IVRA Organizing Committee Secretariat, and a haul of interest and participation from medical professionals and related parties is expected.


links: https://m.whosaeng.com/161171